- Ticker
- AVO.LSE
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Advanced Oncotherapy Plc
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Medical Devices
- Market cap
- 1.04B
- Ent value
- 1.13B
- Price/Sales
- -
- Price/Book
- 17.26
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -9.72%
- 1 year return
- -91.44%
- 3 year return
- -58.01%
- 5 year return
- -47.33%
- 10 year return
- -26.28%
Last updated: 2024-07-23
DIVIDENDS
AVO.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 17.26 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 542.57M |
| EPS (TTM) | - |
| FCF per share (TTM) | -0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | 0.00 |
| Net income (TTM) | 0.00 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.51M |
| Net receivables | 847.71K |
| Total current assets | 32.78M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 153.17M |
| Accounts payable | 11.53M |
| Short/Current long term debt | 59.74M |
| Total current liabilities | 25.95M |
| Total liabilities | 92.65M |
| Shareholder's equity | 60.52M |
| Net tangible assets | -14.96M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -27.23M |
| Capital expenditures (TTM) | 1.79M |
| Free cash flow (TTM) | -29.01M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | -33.26% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| AVO.LSE | S&P500 | |
| Current price drop from All-time high | -99.81% | -7.21% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 30 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -86.73% | -11.26% |
| Avg time to new high | 633 days | 12 days |
| Max time to new high | 3792 days | 1805 days |
COMPANY DETAILS
Marketcap
1.04B
Marketcap category
Small-cap
Description
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Employees
174
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found